Syndax Pharmaceuticals, Inc. (SNDX) Earnings Per Share (EPS)
Syndax Pharmaceuticals, Inc. (SNDX) earnings per share history, EPS estimates, and growth trends. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2016-12-31 | N/A |
| 2017-12-31 | N/A |
| 2018-12-31 | N/A |
| 2019-12-31 | -$1.84 |
| 2020-12-31 | -$1.87 |
| 2021-12-31 | $0.48 |
| 2022-12-31 | -$2.46 |
| 2023-12-31 | -$2.98 |
| 2024-12-31 | -$3.72 |
| 2025-12-31 | -$3.29 |
How SNDX compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| QTRX | Quanterix Corporation | -$2.51 |
| DNLI | Denali Therapeutics Inc. | -$2.97 |
| VSTM | Verastem Inc. | -$3.02 |
| ENTA | Enanta Pharmaceuticals Inc. | -$3.84 |
| MYGN | Myriad Genetics Inc. | -$3.95 |
These are five companies in the same sector as SNDX with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Syndax Pharmaceuticals, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("SNDX")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | SNDX | $20.23 | -0.71% | 0.49M |
| 3 | ||||
| 4 | ||||
| 5 |